EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

CHARACTERISTICS OF ANTI-TUBERCULOSIS DRUG INDUCED HEPATITIS PATIENTS IN COLOMBO DISTRICT, SRI LANKA

Chathuri Weerawardana*, Sandun Undugoda, Achala Upeksha, Dimal Prathapasinghe, Chandimani Undugodage, Ananda Wijayasiri and Shamini Prathapan

ABSTRACT

Background: Tuberculosis is a prevailing disease in Sri Lanka with an estimated detection rate of 65 cases per 100 000 population. One of the main challenges experienced in tuberculosis treatment is anti- tuberculosis drug-induced hepatitis. The objective of this study was to estimate the proportion of tuberculosis patients who were started on anti-TB drug treatment (ATT) developing drug induced hepatitis and describe their characteristics. Methods: The study was conducted as a descriptive cross-sectional study at the Central chest clinic, Borella, Sri Lanka using the data extracted from the medical records of 102 tuberculosis patients who have developed drug induced hepatitis within the time period of 2013-2015 in to an extraction sheet. Patients who were already suffering from hepatitis prior to the treatment, patients with cirrhosis and patients who developed viral hepatitis during treatment were the exclusion criteria. Results: There were 6866 tuberculosis patients, out of which 102 have developed drug induced hepatitis during the treatment (1.4%). Among those 102 patients, the major proportion were less than 55 years of age (60.8%), males 56.9%. pulmonary tuberculosis (53.9%), smear-positive (63.4%), developed hepatitis after 14 days and overdosed with pyrazinamide (63.7%). Conclusions: The prevalence of anti- tuberculosis drug induced hepatitis was 1.4%. From those hepatitis patients, majority were found to be ≤55years, weight >55kg, male, pulmonary tuberculosis, smear positive, overdosed with pyrazinamide with a treatment of >14days duration.

Keywords: Prevalence, tuberculosis, hepatitis, pyrazinamide.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia